MyFinsight
Home
Blog
About
Contact
Download
Download image
Gain on sale of future
royalties, intellectual...
$43,314K
Revenue, net
$36,220K
(77.54%↑ Y/Y)
Income (gain) from
operations
$52,146K
(1072.51%↑ Y/Y)
Total operating
expenses
$25,175K
(10.40%↑ Y/Y)
Cost of product
revenue
$1,897K
(41.04%↑ Y/Y)
Intangible asset
amortization
$316K
(-80.43%↓ Y/Y)
Income (loss) before
income taxes
$44,804K
(2437.19%↑ Y/Y)
Total other (expense)
income
-$7,342K
(-313.12%↓ Y/Y)
Interest and other
income, net
$3,589K
Selling, general and
administrative
$20,783K
(6.33%↑ Y/Y)
Research and development
$4,392K
(34.81%↑ Y/Y)
Fair value
adjustment related to...
-$968K
Net income (loss)
$37,890K
(1322.65%↑ Y/Y)
Income tax expense
$6,914K
(484.94%↑ Y/Y)
Loss on derivative
liability
-$7,216K
Loss on
extinguishment of debt
-$2,756K
Interest expense
$1,711K
Fair value
adjustment related to...
$216K
Back
Back
Income Statement
source: myfinsight.com
ZEVRA THERAPEUTICS, INC. (ZVRA)
ZEVRA THERAPEUTICS, INC. (ZVRA)